CTX112 Clinical Trials
2 recruitingBiologic
Phase 12Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
SLE (Systemic Lupus)Diffuse Cutaneous Systemic SclerosisSystemic Sclerosis+4 more
CRISPR Therapeutics80 enrolled8 locationsNCT06925542
Recruiting
Phase 1Phase 2
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Non-Hodgkin LymphomaB-cell LymphomaB-cell Malignancy
CRISPR Therapeutics AG120 enrolled7 locationsNCT05643742